Article info
Correspondence
Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
- Correspondence to Dr Alexandre Thibault Jacques MARIA, Internal Medicine: Multi-Organic Diseases, Local Referral Center for systemic autoimmune diseases, Montpellier University Hospital, Univ Montpellier, Medical School, Montpellier cedex 5, France; a-maria{at}chu-montpellier.fr.fr; Dr Philippe Guilpain, Internal Medicine: Multi-Organic Diseases, Local Referral Center for systemic autoimmune diseases, Montpellier University Hospital, Univ Montpellier, Medical School, Montpellier University Hospital, Montpellier, France; p-guilpain{at}chu-montpellier.fr
Citation
Rituximab for granulomatosis with polyangiitis in the pandemic of covid-19: lessons from a case with severe pneumonia
Publication history
- Received April 8, 2020
- Accepted April 9, 2020
- First published April 20, 2020.
Online issue publication
December 14, 2020
Article Versions
- Previous version (23 May 2020).
- You are viewing the most recent version of this article.
- latest version (8 January 2022).
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. This article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.https://bmj.com/coronavirus/usage